Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy
Clinical trial NCT01847573 · TERMINATED
Trial details
- NCT number
- NCT01847573
- Sponsor
- Processa Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2016-03-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.